These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38666406)

  • 41. Trust and Support for Cancer Research Biobanks: Insights from Cancer Patients in Poland.
    Domaradzki J; Czekajewska J; Walkowiak D
    Med Sci Monit; 2024 Jun; 30():e944263. PubMed ID: 38867418
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Finding the Value in Biobanks: Enhancing the CTRNet Locator.
    Matzke LA; Tarling TE; Gali B; Dee S; LeBlanc J; Vercauteren S; Watson PH
    Biopreserv Biobank; 2022 Apr; 20(2):132-137. PubMed ID: 34252293
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A Rapid Review on the Value of Biobanks Containing Genetic Information.
    Rodriguez Llorian E; Kopac N; Waliji LA; Borle K; Dragojlovic N; Elliott AM; Lynd LD
    Value Health; 2023 Sep; 26(9):1286-1295. PubMed ID: 36921900
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inter- and intra-biobank networks: classification of biobanks.
    Shickle D; Griffin M; El-Arifi K
    Pathobiology; 2010; 77(4):181-90. PubMed ID: 20616613
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biobank and Pathology Facility: A Successful Combination.
    Alves A; Gibbon A; Carvalho S; Rodriguez-Justo M; Miranda E
    J Biomol Tech; 2022 Apr; 33(1):. PubMed ID: 35837002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Understanding the value of biobank attributes to researchers using a conjoint experiment.
    Batheja D; Goel S; Fransman W; Mantsoki A; Ongarello S; Laxminarayan R
    Sci Rep; 2023 Dec; 13(1):22728. PubMed ID: 38123601
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Quality and reporting practices in an Australian cancer biobank cohort.
    Rush A; Byrne JA
    Clin Biochem; 2016 Apr; 49(6):492-497. PubMed ID: 26708174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 'Access arrangements' for biobanks: a fine line between facilitating and hindering collaboration.
    Fortin S; Pathmasiri S; Grintuch R; Deschênes M
    Public Health Genomics; 2011; 14(2):104-14. PubMed ID: 20689244
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Legacy samples in Finnish biobanks: social and legal issues related to the transfer of old sample collections into biobanks.
    Salokannel M; Tarkkala H; Snell K
    Hum Genet; 2019 Dec; 138(11-12):1287-1299. PubMed ID: 31620872
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sustainability in a Hospital-Based Biobank and University-Based DNA Biorepository: Strategic Roadmaps.
    Seiler CY; Eschbacher J; Bowser R; LaBaer J
    Biopreserv Biobank; 2015 Dec; 13(6):401-9. PubMed ID: 26697909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Toward a Synergistic Operating Model for Westmead Research Hub Biobanks: A Questionnaire Study.
    St George G; Wang XM; Linton J; Douglas N; Carpenter JE; Clarke CL; Heads JA
    Biopreserv Biobank; 2019 Dec; 17(6):570-576. PubMed ID: 31429584
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessing the financial, operational, and social sustainability of a biobank: the Wales Cancer Bank case study.
    Parry-Jones A
    Biopreserv Biobank; 2014 Dec; 12(6):381-8. PubMed ID: 25496149
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Has the biobank bubble burst? Withstanding the challenges for sustainable biobanking in the digital era.
    Chalmers D; Nicol D; Kaye J; Bell J; Campbell AV; Ho CW; Kato K; Minari J; Ho CH; Mitchell C; Molnár-Gábor F; Otlowski M; Thiel D; Fullerton SM; Whitton T
    BMC Med Ethics; 2016 Jul; 17(1):39. PubMed ID: 27405974
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sustainability in Biobanking: Model of Biobank Graz.
    Sargsyan K; Macheiner T; Story P; Strahlhofer-Augsten M; Plattner K; Riegler S; Granitz G; Bayer M; Huppertz B
    Biopreserv Biobank; 2015 Dec; 13(6):410-20. PubMed ID: 26697910
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Balancing the local and the universal in maintaining ethical access to a genomics biobank.
    Heeney C; Kerr SM
    BMC Med Ethics; 2017 Dec; 18(1):80. PubMed ID: 29282045
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The State of Cloud-Based Biospecimen and Biobank Data Management Tools.
    Paul S; Gade A; Mallipeddi S
    Biopreserv Biobank; 2017 Apr; 15(2):169-172. PubMed ID: 28300421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biobanking in health care: evolution and future directions.
    Coppola L; Cianflone A; Grimaldi AM; Incoronato M; Bevilacqua P; Messina F; Baselice S; Soricelli A; Mirabelli P; Salvatore M
    J Transl Med; 2019 May; 17(1):172. PubMed ID: 31118074
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Current practices for access, compensation, and prioritization in biobanks. Results from an interview study.
    Langhof H; Kahrass H; Illig T; Jahns R; Strech D
    Eur J Hum Genet; 2018 Nov; 26(11):1572-1581. PubMed ID: 30089824
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Transformation of the Taiwan Biobank 3.0: vertical and horizontal integration.
    Lin JC; Hsiao WW; Fan CT
    J Transl Med; 2020 Aug; 18(1):304. PubMed ID: 32762757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Market-driven production of biospecimens and the role of NHS hospital-led biobanks.
    Timmons S; Vezyridis P
    Sociol Health Illn; 2017 Sep; 39(7):1242-1257. PubMed ID: 28555937
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.